Conventional therapies in cancer treatment face challenges in delivery of drugs in the body and just the quantity needed, due to the toxic nature of the medicines used that have unwanted side effects.
Nanomaterials have ‘enormous’ potential in cancer treatment, says Dr V Ganesh Kumar, Scientist & Associate Professor at the Centre for Ocean Research (COR), Sathyabama Institute of Science and Technology. “They help alter the drug toxicity profile with enhanced surface characteristics which can diffuse inside the tumour cells. They deliver an optimal concentration of nano drugs at tumour sites and reduce toxicity,” he says.
Nanosynth Group plc (LON:NNN) nano-technology business that originated in Nottingham from a partnership with Nottingham Trent University. Their core mission is to develop unique ways to produce and apply nanoparticles.